Last mentioned: Mar 3, 2026
A wave of Q4 2025 earnings reports across the industrial tech, health-tech, and marketplace sectors reveals a decisive shift from aggressive expansion to operational leverage. Led by Plug Power’s dramatic gross margin recovery, these companies are prioritizing unit economics and AI integration to reach positive EBITDA in 2026.
UroGen Pharma and Senseonics reported strong Q4 2025 results, driven by the successful commercial launches of Zasturi and Eversense 365. Both companies are navigating critical transitions—UroGen through new reimbursement codes and Senseonics by assuming full commercial control—positioning them for significant revenue scaling in 2026.
Healthcare technology and medical device leaders reported strong Q4 2025 results, characterized by aggressive AI acquisitions and successful transitions to direct commercial models. These shifts, led by RadNet and Senseonics, signal a maturing market for digital health platforms and long-term implantable technologies.